Real-time enrollment status for this generalized anxiety disorder clinical trial
Current Status
Recruiting
Checked: September 3, 2026 at 4:27 AM UTC
| NCT Number | NCT07767903 |
| Recruiting Status | Recruiting |
| Condition | Generalized Anxiety Disorder |
| Phase | PHASE3 |
| Target Enrollment | 384 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Otsuka Pharmaceutical Development & Commercialization, Inc. |
| Last Updated on CT.gov | August 17, 2026 (2 weeks ago) |
As of September 3, 2026: Clinical trial NCT07767903 is currently recruiting participants. This phase3 study for generalized anxiety disorder is actively seeking new participants at 2 locations across the United States. The study is sponsored by Otsuka Pharmaceutical Development & Commercialization, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07767903 is actively recruiting participants as of September 3, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07767903 was last updated 2 weeks ago (August 17, 2026). HelloStudys verifies this status automatically.